Note: Ingredients listed on restricted chemical lists
EC/CAS
202-049-5/91-20-3
Name of the chemical
Naphthalene,3
Concentration
<0.01
EC/CAS
265-148-2
Name of the chemical
Distillates (petroleum), hydrotreated middle
Concentration
≤4 ≤4
General Information
Version
3.1
Revision date
2024-11-20
Product name
WOLF LDS FLUID
Emergency telephone
0032 (0)3 870 00 00, +353 1 809 2566, +353 1 809 2166, +972 4 854 1900, +356 2545 6508, +46 10 456 6700
Icons in SDS
Company Information
company name
WOLF OIL CORPORATION N.V
e-mail address of the competent person responsible for the Safety Data Sheet
msds@wolfoil.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304, H332
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS08
Signal word
Danger
Contains
Hydrogenated dimerization products of 1-decene and reaction products of hydrogenated 1- decene; Hydrogenated dimerization products of 1-decene, 1-dodecene and 1-octene; 1- Dodecene dimer with 1-Decene, hydrogenated; Petroleum distillates, hydrotreated middle; 1-Decene, homopolymer, hydrogenated
Hazard statements
H304 - May be fatal if swallowed and enters airways. H332 - Harmful if inhaled.
Precautionary statements
P102 - Keep out of reach of children. P271 - Use only outdoors or in a well-ventilated area. P301+P310+P331 - IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. Do NOT induce vomiting. P304+P340 - IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P405 - Store locked up. P501 - Dispose of contents/container in accordance with local/regional/national/international regulations.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
